Refractory Digital Ulcers Treated by Botulinum Toxin and Endothelin Receptor-1 Antagonist in Anti-MDA5-Antibody-Positive Dermatomyositis

Detalles Bibliográficos
Autores principales: Min, Hong Ki, Kim, Hae-Rim, Lee, Sang-Heon, Park, Sung-Hye, Oh, Jeeyoung, Choi, Kyomin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974839/
https://www.ncbi.nlm.nih.gov/pubmed/31942775
http://dx.doi.org/10.3988/jcn.2020.16.1.160
_version_ 1783490180103012352
author Min, Hong Ki
Kim, Hae-Rim
Lee, Sang-Heon
Park, Sung-Hye
Oh, Jeeyoung
Choi, Kyomin
author_facet Min, Hong Ki
Kim, Hae-Rim
Lee, Sang-Heon
Park, Sung-Hye
Oh, Jeeyoung
Choi, Kyomin
author_sort Min, Hong Ki
collection PubMed
description
format Online
Article
Text
id pubmed-6974839
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Korean Neurological Association
record_format MEDLINE/PubMed
spelling pubmed-69748392020-02-04 Refractory Digital Ulcers Treated by Botulinum Toxin and Endothelin Receptor-1 Antagonist in Anti-MDA5-Antibody-Positive Dermatomyositis Min, Hong Ki Kim, Hae-Rim Lee, Sang-Heon Park, Sung-Hye Oh, Jeeyoung Choi, Kyomin J Clin Neurol Letter to the Editor Korean Neurological Association 2020-01 2019-11-28 /pmc/articles/PMC6974839/ /pubmed/31942775 http://dx.doi.org/10.3988/jcn.2020.16.1.160 Text en Copyright © 2020 Korean Neurological Association http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Min, Hong Ki
Kim, Hae-Rim
Lee, Sang-Heon
Park, Sung-Hye
Oh, Jeeyoung
Choi, Kyomin
Refractory Digital Ulcers Treated by Botulinum Toxin and Endothelin Receptor-1 Antagonist in Anti-MDA5-Antibody-Positive Dermatomyositis
title Refractory Digital Ulcers Treated by Botulinum Toxin and Endothelin Receptor-1 Antagonist in Anti-MDA5-Antibody-Positive Dermatomyositis
title_full Refractory Digital Ulcers Treated by Botulinum Toxin and Endothelin Receptor-1 Antagonist in Anti-MDA5-Antibody-Positive Dermatomyositis
title_fullStr Refractory Digital Ulcers Treated by Botulinum Toxin and Endothelin Receptor-1 Antagonist in Anti-MDA5-Antibody-Positive Dermatomyositis
title_full_unstemmed Refractory Digital Ulcers Treated by Botulinum Toxin and Endothelin Receptor-1 Antagonist in Anti-MDA5-Antibody-Positive Dermatomyositis
title_short Refractory Digital Ulcers Treated by Botulinum Toxin and Endothelin Receptor-1 Antagonist in Anti-MDA5-Antibody-Positive Dermatomyositis
title_sort refractory digital ulcers treated by botulinum toxin and endothelin receptor-1 antagonist in anti-mda5-antibody-positive dermatomyositis
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974839/
https://www.ncbi.nlm.nih.gov/pubmed/31942775
http://dx.doi.org/10.3988/jcn.2020.16.1.160
work_keys_str_mv AT minhongki refractorydigitalulcerstreatedbybotulinumtoxinandendothelinreceptor1antagonistinantimda5antibodypositivedermatomyositis
AT kimhaerim refractorydigitalulcerstreatedbybotulinumtoxinandendothelinreceptor1antagonistinantimda5antibodypositivedermatomyositis
AT leesangheon refractorydigitalulcerstreatedbybotulinumtoxinandendothelinreceptor1antagonistinantimda5antibodypositivedermatomyositis
AT parksunghye refractorydigitalulcerstreatedbybotulinumtoxinandendothelinreceptor1antagonistinantimda5antibodypositivedermatomyositis
AT ohjeeyoung refractorydigitalulcerstreatedbybotulinumtoxinandendothelinreceptor1antagonistinantimda5antibodypositivedermatomyositis
AT choikyomin refractorydigitalulcerstreatedbybotulinumtoxinandendothelinreceptor1antagonistinantimda5antibodypositivedermatomyositis

Ejemplares similares